ArticleBone & joint research2025
Effect of human adipose stem cell-derived mitochondrial transplantation on the activity of chronically injured anterior cruciate ligament cells.
Article in Bone & joint research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Highly bio-adapted hydrogels for tendon-bone interface regeneration: Natural healing inspiration, design strategies, and biomedical potential.Bioactive materials · 2026Review
- Intercellular Mitochondrial Transfer: Implications in Cardiovascular Health.Circulation research · 2026Review
- Anterior Cruciate Ligament Tissue Engineering: Biological Principles, Engineered Substitutes, and Preclinical Outcomes.Bioengineering (Basel, Switzerland) · 2026Review
- Mitochondrial transfer and transplantation in tendon, ligament, and enthesis repair: current evidence, mechanistic rationale, and regenerative opportunities.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Mitochondrial transplantation has been proposed as a potential treatment for injured ligament tissue. This study aimed to investigate the relationship between the time from injury to surgery and the activity of injured anterior cruciate ligament (ACL) cells. Additionally, we evaluated the effectiveness of mitochondrial transplantation in chronically injured ACL cells and in an in vivo ACL partial tear animal model. Methods: First, ACL injured tissue from rabbits (n = 6 for each timepoint) was harvested at two (acute), four (subacute), and eight (chronic) weeks following ACL transection. We investigated cell proliferation, migration capability, and the expression of collagen synthesis, vascular endothelial growth factor ( Results: After injury, the highest cell activity was observed at four weeks. Immunohistochemical staining showed that hADSCs-mitochondria were taken up by the eight-week injured ACL cells, leading to subsequent improvements in cell viability, migration capability, and collagen synthesis, and Conclusion: The optimal timing of ACL reconstruction is four to six weeks after injury due to peak cell activity. Mitochondrial transplantation improves the activity of chronically injured ACL cells and enhances collagen synthesis in ACL partial tears, highlighting its potential as a treatment for improving their regenerative capability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.